Company / R&D per Share
Avidity Biosciences, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.06
FY2025
5-year range
$2.44 / $4.06
FY2021-FY2025
Trend
+49.2%
vs FY2024
Sector context
#50 of 208
Health Care
What the data says
Avidity Biosciences, Inc.'s r&d per share of $4.06 is higher than 76% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 8 years, ranging from $1.74 in FY2020 to $5.36 in FY2019.
Based on SEC 10-K filings.
4.06 in FY2025 with a 5-year CAGR of +18.5%. Top quartile in the Health Care sector.
Improved from $2.62 to $4.06 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +12.1%
- 5-Year CAGR
- +18.5%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 208This company $4.06 Sector average $28.82
▼
-85.9% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 49.2% year-over-year.
- Ranks #50 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.06 | +49.2% |
| FY2024 | $2.72 | +4.0% |
| FY2023 | $2.62 | -9.3% |
| FY2022 | $2.88 | +18.1% |
| FY2021 | $2.44 | +40.7% |
| FY2020 | $1.74 | -67.6% |
| FY2019 | $5.36 | +57.4% |
| FY2018 | $3.41 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026